生物通首页 > 今日动态> 专题总汇> Illumina新款测序仪上市：NextSeq 500 & HiSeq X Ten 第32届摩根大通保健大会（JP Morgan Healthcare Conference）于1月13日在美国旧金山拉开帷幕。Illumina公司的CEO Jay Flatley在会议上宣布，Illumina将推出两款新的测序平台：NextSeq 500和HiSeq X Ten ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

We recently compiled a list of the Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth ...

Using Illumina’s NovaSeq X Plus sequencer, the Institute can sequence over 20,000 whole genomes each year, significantly ...

Quest Partners LLC trimmed its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 10.3% during the third quarter, ...

Gen Molecular Tools for Malaria Surveillance" explores the latest advancements in molecular diagnostics and surveillance technologies crucial for advancing malaria elimination efforts. This thematic ...

Illumina raised the curtain on a revamp of its flagship tumor profiling test, which aims to offer faster turnarounds, fewer ...

Illumina to release new version of its flagship cancer research assay, TruSight Oncology 500 v2: San Diego Thursday, November 21, 2024, 16:00 Hrs [IST] Illumina, Inc., a global le ...